SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031827
Filing Date
2019-08-13
Accepted
2019-08-13 16:36:41
Documents
80
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-10q_20190630.htm   iXBRL 10-Q 3268210
2 EX-10.12 adpt-ex1012_196.htm EX-10.12 537164
3 EX-31.1 adpt-ex311_238.htm EX-31.1 24795
4 EX-31.2 adpt-ex312_237.htm EX-31.2 26204
5 EX-32.1 adpt-ex321_235.htm EX-32.1 11630
6 EX-32.2 adpt-ex322_236.htm EX-32.2 13084
  Complete submission text file 0001564590-19-031827.txt   11338788

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA adpt-20190630.xsd EX-101.SCH 57340
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adpt-20190630_cal.xml EX-101.CAL 49042
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adpt-20190630_def.xml EX-101.DEF 232309
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20190630_lab.xml EX-101.LAB 425186
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20190630_pre.xml EX-101.PRE 369841
12 EXTRACTED XBRL INSTANCE DOCUMENT adpt-10q_20190630_htm.xml XML 2284745
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 191021188
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1